PATENT CLAIM ANALYSIS

Application Number: 16129589
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-05
Patent Classification: ["514", "456000"]

Abstract:
Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.

Claim (Index 20):
The method of  claim 18 , wherein the cancer has lost sensitivity to a chemotherapeutic agent, anti-cancer agent, or radiation therapy.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15456182', '13881609', '15622569', '13881599', '15961259']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7621835438490422
- 35 USC 102 Novelty (BERT): 0.5155425544895986
- Combined Prediction Score: 0.7375194449130978
- Mean Citation Score: 240.421246
- Max Citation Score: 260.15958
- Similarity Product: 157.1533124624133

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test